---
schema_version: "secwatch.filing_event.v1"
accession: "0001057877-23-000064"
form_type: "8-K"
ticker: "IDA"
cik: "0001057877"
company_name: "IDACORP INC"
filed_at: "2023-11-09T23:59:59+00:00"
generated_at: "2026-06-08T06:01:48.180030+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# IDACORP enters forward sale agreement for 3.22M shares at $90.016/share

## Summary
- Aggregate of 3,221,982 shares subject to forward sale agreements with Morgan Stanley & Co. LLC.
- Initial forward price $90.016/share; settlement at IDACORP's discretion by November 7, 2024.
- Underwriters sold borrowed shares in public offering; proceeds deferred until physical settlement.
- Dilution to EPS occurs upon physical or net share settlement; no immediate EPS impact under treasury stock method unless market price exceeds forward price.
- Forward price subject to daily adjustment based on overnight bank funding rate minus 0.75% spread and expected dividends.

## SEC filing metadata
- accession: 0001057877-23-000064
- form_type: 8-K
- ticker: IDA
- cik: 0001057877
- company_name: IDACORP INC
- filed_at: 2023-11-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1057877/000105787723000064/0001057877-23-000064-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1057877/000105787723000064/ida-20231107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001057877-23-000064
- JSON: https://secwatch.observer/filing/0001057877-23-000064.json
- Plain text: https://secwatch.observer/filing/0001057877-23-000064.txt

## Key facts
- Material Agreements
  IDACORP INC entered into Forward Sale Agreement with Morgan Stanley & Co. LLC valued at aggregate of 2,801,724 shares (effective 2023-11-07).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: Morgan Stanley & Co. LLC
  - Value: aggregate of 2,801,724 shares
  - Effective: 2023-11-07
  source text: On November 7, 2023, IDACORP, Inc. ("IDACORP”) entered into a forward sale agreement (the “Forward Sale Agreement”) with Morgan Stanley & Co. LLC (the “Forward Counterparty”), relating to an aggregate of 2,801,724 shares (the “Forward Shares”) of IDACORP’s common stock, without par value (the “Common Stock”), to be borrowed from third parties and sold by the Forward Counterparty to the Underwriters
  evidence_url: https://www.sec.gov/Archives/edgar/data/1057877/000105787723000064/0001057877-23-000064-index.htm
- Material Agreements
  IDACORP INC entered into Additional Forward Sale Agreement with Morgan Stanley & Co. LLC valued at aggregate of 420,258 shares of Common Stock (effective 2023-11-08).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: Morgan Stanley & Co. LLC
  - Value: aggregate of 420,258 shares of Common Stock
  - Effective: 2023-11-08
  source text: On November 8, 2023, IDACORP entered into an additional forward sale agreement with the Forward Counterparty relating to an aggregate of 420,258 shares of Common Stock (the “Additional Forward Sale Agreement”
  evidence_url: https://www.sec.gov/Archives/edgar/data/1057877/000105787723000064/0001057877-23-000064-index.htm
- Material Agreements
  IDACORP INC entered into Underwriting Agreement with Wells Fargo Securities, LLC and Morgan Stanley & Co. LLC (effective 2023-11-07).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Wells Fargo Securities, LLC and Morgan Stanley & Co. LLC
  - Effective: 2023-11-07
  source text: On November 7, 2023, IDACORP entered into an Underwriting Agreement (the “Underwriting Agreement”) with Wells Fargo Securities, LLC and Morgan Stanley & Co. LLC, as representatives of the several underwriters
  evidence_url: https://www.sec.gov/Archives/edgar/data/1057877/000105787723000064/0001057877-23-000064-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.